Skip to content

Resuscitation Quick Actions • First 2 Minutes

High-Acuity

IV Calcium Salts

Calcium Chloride 10% 1–2g (10–20 mL) IV central line OR Calcium Gluconate 10% 3–6g (30–60 mL) peripheral IV over 5–10 min; repeat q10–15 min x 3

HIET Protocol

Regular Insulin 1 unit/kg IV bolus + 1 unit/kg/hr infusion; titrate up to 5–10 units/kg/hr along with D10W/D20W for euglycemia

First-Line Vasopressors

Norepinephrine 0.05–0.5 mcg/kg/min + Epinephrine 0.05–0.5 mcg/kg/min for combined alpha-vasoconstriction and beta-inotropy

Methylene Blue (Vasoplegia)

1.5–2.0 mg/kg IV over 20–60 min for nitric-oxide mediated refractory vasoplegic vasodilatory shock

Whole Bowel Irrigation (WBI)

Polyethylene glycol (GoLYTELY) 1.5–2.0 L/hr via NG tube for massive sustained-release (SR/XL) ingestions presenting < 4–6 hours

Hyperglycemia Correlation

Blood glucose > 200–300 mg/dL without known diabetes indicates severe L-type calcium channel inhibition in pancreatic beta cells

Bottom-Line Clinical Pearl

Calcium channel blocker overdose is the most lethal prescription cardiovascular toxicity. Non-dihydropyridines (verapamil, diltiazem) cause profound myocardial depression, sinus bradycardia, and high-grade AV block. Dihydropyridines (amlodipine, nifedipine) produce catastrophic peripheral vasoplegic shock with reflex tachycardia initially. Hyperglycemia correlates directly with toxicity severity due to blockade of calcium-mediated insulin exocytosis from pancreatic beta-islet cells. Initiate aggressive IV calcium and early HIET (1–10 units/kg/hr); add norepinephrine/epinephrine and methylene blue for vasoplegia.

1. Pathophysiology: Dihydropyridines vs. Non-Dihydropyridines

Calcium channel blockers antagonize voltage-gated L-type calcium channels in the heart, peripheral vascular smooth muscle, and pancreatic beta-islet cells. In overdose, receptor selectivity is lost, but primary clinical phenotypes differ significantly:

Class & AgentsPrimary Site of ActionClinical Features in OverdoseHemodynamic Profile
Non-Dihydropyridines (Verapamil, Diltiazem)Myocardium & SA/AV Nodal Conduction TissueSevere sinus bradycardia, PR prolongation, complete heart block, junctional escape, profound myocardial depression, acute pulmonary edemaCardiogenic Shock: Low Cardiac Output, Elevated SVR or Low SVR, High CVP
Dihydropyridines (Amlodipine, Nifedipine, Nicardipine)Peripheral Vascular Arteriolar Smooth MuscleMassive systemic arteriolar vasodilation, warm extremities, reflex tachycardia initially followed by terminal bradycardia as selectivity is lostVasoplegic/Distributive Shock: High/Normal Cardiac Output, Extremely Low SVR

2. Hyperglycemia as a Prognostic Biomarker

Endogenous insulin secretion by pancreatic beta cells is an active calcium-dependent exocytic process triggered by calcium influx through L-type channels. In significant CCB overdose, beta-cell channel blockade arrests insulin secretion, producing marked hyperglycemia (often 250–500+ mg/dL). In clinical trials, the magnitude of initial hyperglycemia correlates directly with the degree of shock, need for vasopressors, and in-hospital mortality.

3. Stepwise Medical Resuscitation Protocol

StepTherapeutic InterventionDose & Administration Pearl
1. Volume ResuscitationBalanced Crystalloids (Plasmalyte or LR)1–2 L bolus; avoid over-resuscitation because impaired inotropy predisposes to iatrogenic pulmonary edema.
2. Intravenous CalciumCalcium Chloride 10% 1–2g IV central OR Calcium Gluconate 10% 3–6g IV peripheralAdminister over 5–10 min; repeat every 10–15 min up to 3–4 doses, then initiate continuous infusion (0.2–0.4 mL/kg/hr of 10% CaCl2).
3. Early HIETRegular Insulin 1 unit/kg IV bolus + 1 unit/kg/hr infusionTitrate aggressively up to 5–10 units/kg/hr. Administer supplemental D10W/D20W only as needed to maintain euglycemia (100–200 mg/dL).
4. Vasoactive InotropesNorepinephrine + Epinephrine infusionsStart norepinephrine 0.1–0.5 mcg/kg/min for vasoconstriction; add epinephrine 0.05–0.5 mcg/kg/min for chronotropic and inotropic support.
5. Vasoplegia RescueMethylene Blue 1.5–2.0 mg/kg IV over 20 minInhibits inducible nitric oxide synthase (iNOS) and soluble guanylyl cyclase; reverses amlodipine-induced vascular smooth muscle paralysis.
6. DecontaminationWhole Bowel Irrigation (WBI)Indicated for confirmed large ingestions of sustained-release (ER/SR/XL) formulations presenting within 4–6 hours with a protected airway.

Critical Pitfall / Contraindication

BEWARE EXTENDED-RELEASE AMITRIPTYLINE & AMLODIPINE DELAYS: Extended-release amlodipine, verapamil SR, and diltiazem CD ingestions may present completely asymptomatic with normal vitals for 6 to 12 hours post-ingestion before crashing into catastrophic refractory vasoplegia. Every patient with suspected extended-release CCB ingestion requires at least 24 hours of intensive cardiac monitoring.

Board & Shelf Drill 5 Questions • Untimed Tutor Mode

Test Your Calcium Channel Blocker Toxicity & Vasoplegic Shock Clinical Acumen

Directly launch an active-recall practice block from our 8,400+ validated COMLEX Level 1, 2-CE & 3 board question bank with complete explanations.